Detection Technology, a global leader in X-ray detector solutions, unveils a comprehensive portfolio of flat panel X-ray detectors at the RSNA 2024 exhibition to advance
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic
Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women’s health, today announces a $10.4 million strategic investment from the Bill &
A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high-
Researchers at The University of Manchester have identified several ways for health leaders to tackle the problem of tooth decay in children in England.
We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and treatments we receive?
This study explores urinary pentosidine as a potential biomarker for muscle strength and physical performance in young men, revealing significant inverse correlations with key musculoskeletal
“It’s a real regulatory dilemma here.” — Donald Kohn, MD, of the University of California Los Angeles, at an FDA advisory committee meeting to discuss
HOUSTON — Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to
Baloescu is an emergency physician, assistant professor, and AI researcher. Microsoft’s new artificial intelligence (AI)-powered healthcare suite plans to “shape a healthier future” through advances